slides · global inventory
Diagram
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 23,622
Current window 16,981-17,010
Pages 788
Rows per page 30
Component
16,981-17,010 of 23,622
16
The slide uses a value-chain style process flow to map specific A.I. tools to stages of drug development.Evotec | Investor Presentation Deck | 49 slides · Evotec
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
20
The diagram functions as a flywheel or circular process model.Evotec | Investor Presentation Deck | 49 slides · Evotec
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
31
The slide uses a chevron-based process flow to map functional capabilities across the drug development lifecycle.Evotec | Investor Presentation Deck | 49 slides · Evotec
Conference presentation Investor relations Beat · Action1 hit
44
The chart uses a complex network of bidirectional arrows to define reporting, advisory, and support relationships.Evotec | Investor Presentation Deck | 49 slides · Evotec
Conference presentation Investor relations Beat · Action1 hit
47
The slide uses a circular diagram to represent the 'Starting points to fuel EVOequity portfolio' and lists company logos under three categories: Equity Holding, Minority Shareholdings, and BRIDGES.Evotec | Investor Presentation Deck | 49 slides · Evotec
Conference presentation Investor relations Beat · Action1 hit
03
The slide uses a split-screen layout to contrast internal R&D with external partnerships, unified by a central 'Multiple Discovery Programmes' icon stack.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · What Is1 hit
07
Exscientia | Investor Presentation Deck | 93 slidesExscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
08
The slide uses a hub-and-spoke diagram centered on a human silhouette to represent the integration of clinical design, data generation, target identification, AI design, model-based learning, and biomarkers.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Loop · Golden Circle1 hit
14
The slide uses a circular, iterative process flow to represent the R&D pipeline.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Loop · Golden Circle1 hit
15
The slide uses a process-oriented timeline to show technological progression from simple GPCRs to complex novel targets.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
16
The slide uses a timeline framework to map partnership complexity against platform value.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
18
The slide uses a central vertical process flow with branching inputs and outputs.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
19
The slide uses a timeline-like axis to represent 'Rank' and shows the shift in target positioning based on prompt precision.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
20
The slide uses a numbered process flow mapped to a screenshot of a research interface.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
26
The slide uses a process flow diagram showing the transition from Target Product Profile (table) to MPO (code snippet) to Merit (scatter plot).Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
27
The diagram illustrates a multi-modal AI pipeline for drug discovery, emphasizing flexibility in data inputs and model architectures.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
32
The diagram is a classic flywheel or continuous improvement loop.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
33
Includes a process flow diagram for Chemical Synthesis, Compound Management, and Biological Testing.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
34
The slide uses a flywheel-style circular process diagram to show the integration of digital design and physical lab automation.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
36
Uses a contrast-pairs framework to highlight the shift from common/similar processes to unique/varied processes.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
37
The slide uses a process flow diagram to map specific robotic solutions to different stages of laboratory automation.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
39
The slide uses a circular process flow to represent a proprietary R&D pipeline.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
40
The slide uses a process flow to demonstrate the efficacy of the platform in a specific patient case.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
41
The slide uses Kaplan-Meier curves to demonstrate clinical efficacy of the platform's drug prioritization.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
42
The slide uses a converging timeline/process flow to show how different patient types (Ovarian cancer vs AML) feed into a unified precision medicine testing platform.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
48
The slide outlines a standard oncology clinical trial design (Phase 1/2) with a transition point at RP2D (Recommended Phase 2 Dose).Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
57
Includes a Venn diagram and two line charts showing Log2FoldChange vs concentration.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
64
The slide uses a hub-and-spoke diagram to illustrate the interaction of LSD1 with various protein complexes, receptors, and RNAs.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
65
The slide uses a biological process diagram to explain the mechanism of action for a drug candidate ('539).Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
66
The slide uses a process flow diagram to explain the therapeutic mechanism.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit